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Engineering of metal-ion sites as distance constraints in
structural and functional analysis of 7TM receptors
Christian E Elling, Kenneth Thirstrup, Søren M Nielsen, Siv A Hjorth 
and Thue W Schwartz
G-protein-coupled receptors with their seven
transmembrane (7TM) segments constitute the largest
superfamily of proteins known. Unfortunately, still only
relatively low resolution structures derived from
electron cryo-microscopy analysis of 2D crystals are
available for these proteins. We have used artificially
designed Zn(II) metal-ion binding sites to probe 7TM
receptors structurally and functionally and to define
some basic distance constraints for molecular
modeling. In this way, the relative helical rotation and
vertical translocation of transmembrane helices TM-II,
TM-III, TM-V, and TM-VI of the tachykinin NK-1
receptor have been restricted. Collectively, these zinc
sites constitute a basic network of distance
constraints that limit the degrees of freedom of the
interhelical contact faces in molecular models of 7TM
receptors. The construction of artificially designed
metal-ion sites is discussed also in the context of
probes for conformational changes occurring during
receptor activation.
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Introduction
A general and reliable method is still lacking for the pro-
duction of large quantities of membrane proteins and for
growing 3D crystals of these suitable for crystallographic
analysis. Concerning 7TM G-protein-coupled receptors,
electron cryo-microscopy has been performed on 2D
crystals of rhodopsin [1–3], but the resolution of these
structures is still limited and does not yet allow identifi-
cation of the individual helices. The density map of
rhodopsin has been analyzed systematically integrating
the amino acid sequence and mutational data from multi-
ple 7TM receptors in an attempt to assign the sequence
to the low-resolution data available. This is based on the
assumption that the receptors share a common fold in the
transmembrane region at least within the individual sub-
families [4,5]. Previously, Engelman et al. [6] had per-
formed a similar analysis of the proton pump
bacteriorhodopsin and assigned amino acid sequence to
the low-resolution structural data before high-resolution
data were available. Interestingly, the proposed assign-
ment from this early work later turned out to be consis-
tent with high-resolution data. Nevertheless, due to the
limited amount of real structural information available,
current models of G-protein-coupled 7TM receptors are
mostly based on speculation.
Results and discussion
To test the validity of current 7TM receptor models, we
have introduced artificial intrahelical and interhelical
metal-ion binding sites in the transmembrane segments
of the tachykinin NK-1 and the k-opioid receptor [7–9].
The coordination of metal-ions to metal-ion binding sites
is well characterized in numerous high-resolution X-ray
structures of soluble proteins; for example, distances
from the chelating atoms to the metal-ion as well as the
preferred conformation of the chelating sidechains are
known [10–13]. By screening the receptor constructs in a
competition binding assay, using radiolabeled agonists or
antagonists, only metal-ion sites that successfully
compete for the receptor are selected. This is advanta-
geous as not only structural but also functional informa-
tion about the receptor is extracted from the sites
identified. However, ‘silent’ sites that do not affect the
radioligand binding are not detected in this screening
procedure. Using designed metal-sites in 7TM receptors,
we have been able to address basic issues concerning
their structure, e.g. the relative helical register and the
overall orientation of the transmembrane helices —
issues for which very little experimentally based infor-
mation was available.
Exchange of an antagonist binding site with a metal-ion site
Extensive mutational analysis of the tachykinin NK-1
receptor had previously mapped the major contact points
for a non-peptide NK-1 receptor antagonist, CP96,345, to
opposing faces of transmembrane (TM) helices V (TM-V)
and TM-VI with additional interaction points present on
TM-III and TM-IV [14–22]. By systematically substitut-
ing residues in the presumed binding site for CP96,345
with the metal-ion coordinating residue, histidine, we
were able to gradually decrease the affinity for this antag-
onist while concomitantly increasing the apparent affinity
for Zn(II) [7]. In a double substitution mutant containing
two histidines at the top of TM-V (including one found in
the native receptor) and one histidine at the top of TM-
VI, the binding site for CP96,345 was virtually exchanged
with a submicromolar affinity zinc site of a presumably
tridentate nature. Importantly, in this construct, only the
apparent affinity of CP96,345 had been affected, whereas
the affinity of the endogenous agonist substance P, as
well as a range of other nonpeptide antagonists of the
NK-1 receptor, was virtually unaffected by the substitu-
tions [7,23]. This indicates that the native structure of the
receptor was not disrupted by the two substitutions.
Hence, the CP96,345 binding site could be selectively
exchanged with a zinc site defined by three histidine
residues in the exterior part of TM-V and TM-VI (Fig. 1).
Transfer of metal-ion sites between 7TM receptors
It is generally assumed that the tertiary structure of the
transmembrane region of 7TM receptors is similar at least
within the three subfamilies. However, surprisingly little
experimental evidence has been generated to support this.
Similarly, in only very few cases have the binding sites for
the natural ligands of 7TM receptors been well defined.
In the adrenergic system, the interaction points of the
monoamine ligand have been located to residues on TM-
III, TM-V and TM-VI [24,25]. In rhodopsin, the ‘ligand’
retinal forms a covalent bond via a protonated Schiff base
linkage to the e-amino group of a lysine residue in TM-
VII, with a glutamate residue in TM-III as counterion
[26]. Still, these receptors constitute less than 1% of the
cloned 7TM receptors. Many other reports have suggested
interaction points between the ligand and the receptor,
but in most cases these derive from mutational studies
where mutation of particular residues has negatively
affected the affinity of the ligand, i.e. loss of function, and
in these cases indirect effects are difficult to exclude [27].
The k-opioid receptor belongs to the rhodopsin-like
receptor family but has only ~30% amino acid sequence
identity in the transmembrane domains to the previously
discussed tachykinin NK-1 receptor. Having introduced a
high-affinity tridentate zinc site in the NK-1 receptor, the
maximal distance of the a-carbons and metal coordinating
atoms of the three residues involved in binding of the
metal had been spatially defined. We therefore attempted
to move the zinc site from the NK-1 receptor to the k-
receptor by genetically transferring the three histidines to
the corresponding positions in TM-V and TM-VI of the k-
receptor [9]. Importantly, the previously unresponsive k-
receptor now gained submicromolar affinity for Zn(II)
comparable to the affinity found when the zinc site was
introduced in the NK-1 receptor. This indicates that the
two distantly related receptors share a common arrange-
ment of the transmembrane helices at least at the top of
TM-V and TM-VI.
Building a network of distance constraints in 7TM receptors
With the distance constraint deduced from the tridentate
zinc site composed of two residues on TM-V and one
residue on TM-VI, the relative rotation and vertical translo-
cation of the involved helices was restricted in our molecu-
lar model. Although this information was valuable for
directing the helical register, more constraints are obviously
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Figure 1
Binding of Zn(II) to histidine-substituted NK-1 receptor mutants
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Helical wheel diagram of the extracellular part of the transmembrane
helices in the tachykinin NK-1 receptor indicating the network of
interconnected Zn(II) sites. The helical wheels are arranged in an anti-
clockwise orientation as viewed from outside the cell essentially
according to the Baldwin interpretation [4] of the electron density map
of bovine rhodopsin derived from electron cryo-microscopy analysis by
Schertler et al. [1,3]. In TM-V and TM-VI are shown (in white on black)
V:01 (193) (generic numbering system for 7TM receptors followed by
the specific NK-1 residue number [5]), V:05 (197), and VI:24 (272),
which can form interhelical bis-histidine sites and even a very high
affinity tridentate Zn(II) site when histidine residues are placed at all
three positions [7]. In TM-III are shown positions III:04 (108) and III:05
(109), which can form interhelical bis-histidine Zn(II) sites with,
respectively, II:24 (92) and V:01 (193) [8]. The relative locations are
indicated of positions 138 and 251 of rhodopsin (black on grey),
which can form an interhelical bis-histidine Zn(II) site [32]. These two
residues are located intracellularly and may be in close spatial
proximity due to the presumed tilting of TM-III towards the inner pole of
TM-V [1–3,29]. Summarized in the table are the apparent affinities of
the artificial zinc sites engineered in the tachykinin NK-1 receptor [7,8].
needed on several helices to construct experimentally
based models of 7TM receptors. It has been proposed that
TM-III constitutes a ‘central column’ in the seven-helical
bundle [4,5,28] as reflected in the electron density maps of
rhodopsin [1–3,29]. Having restricted the relative orienta-
tion of TM-V and TM-VI in the NK-1 receptor, we
attempted next to design interhelical bis-histidine zinc sites
involving residues on TM-III and TM-V in order to further
restrict our model [8]. Systematically scanning opposing
faces of the helices, by sequentially substituting residues
one-by-one for histidine on TM-III while maintaining his-
tidines at fixed positions on TM-V, we constructed a
bidentate zinc site. Importantly, the bis-histidine site
involved a position on TM-V which was used in the con-
struction of the tridentate site between TM-V and TM-VI
(Fig. 1). Hence, the relative helical rotation and vertical
translocation of TM-III, TM-V and TM-VI was further
restricted by the new spatial connection. To obtain addi-
tional structural constraints, we next attempted to design a
zinc site between TM-II and TM-III. By utilizing the
neighboring residue on TM-III to the position used in the
site involving TM-III and TM-V, which in the wild-type
receptor is a naturally occurring histidine, a new bidentate
zinc site was constructed between TM-II and TM-III
(Fig. 1). Thus, apparent spatial connections were estab-
lished by engineering bidentate and tridentate zinc sites
inducing restrictions on the possible relative helical rotation
and vertical translocation of TM-II, TM-III, TM-V and
TM-VI of the NK-1 receptor [7,8]. 
Collectively, these sites constitute a basic network of dis-
tance constraints that limit the degrees of freedom of the
interhelical contact faces in molecular models of 7TM
receptors (Fig. 1). For example, when constructing a mole-
cular model of a 7TM receptor, the a-carbons of the pairs
of residues defining the zinc sites must be within a dis-
tance of 13 Å. Furthermore, little experimental evidence
has been reported that can help to discriminate between
the two possible basic arrangements of the seven-helical
bundle: clockwise versus anti-clockwise [30,31]. Due to
the limited length of the connecting loops, it is presumed
that the transmembrane segments are arranged in a
sequential circular manner, i.e. that TM-I is followed by
TM-II followed by TM-III etc. [4,5]. A sequential helical
bundle can be arranged either clockwise or anti-clockwise
(Fig. 2). Importantly, when the positions defining the zinc
sites between TM-II and TM-III and between TM-III
and TM-V are plotted onto either arrangement, it is appar-
ent that an anti-clockwise arrangement, as viewed from
the extracellular space, is preferred [8]. Although the pair
of residues defining the individual sites can be brought
into proximity by helical rotation in both arrangements,
only in the anti-clockwise arrangement can both pairs be
satisfied at the same time [8]. 
Recently, the zinc site engineering technique was applied
by Bourne and co-workers [32] on the intracellular ends of
TM-III and TM-VI in rhodopsin. These metal-ion sites
were of apparent affinities comparable to the bidentate
sites constructed in the NK-1 receptor and the k-opioid
receptor [7–9]. However, when plotted on a helical wheel
diagram, the positions identified in rhodopsin are not con-
sistent with those identified in the NK-1 and k-receptor.
As shown in Figure 1, the two positions that together
produce a bidentate zinc site in rhodopsin are apparently
located relatively far apart in the helical wheel diagram,
which importantly depicts only the extracellular part of
the transmembrane segments. In the structures derived by
electron microscopy of even invertebrate rhodopsin it
appears that TM-III is rather tilted and that its intracellu-
lar end is probably reaching over towards TM-V [1–3,29].
In such a scenario, the pair of residues may in fact be in
much closer spatial proximity allowing for the formation of
the metal-ion sites. Hence, the apparent discrepancy
between the two structures, as inferred from the designed
zinc sites, does not necessarily indicate that the folds of
the receptors are fundamentally different in the trans-
membrane region.
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Figure 2
The bis-histidine Zn(II) sites support an anti-
clockwise arrangement of the transmembrane
helices of the NK-1 receptor. A helical wheel
diagram of the NK-1 receptor is shown in an
anti-clockwise and in a clockwise
arrangement as viewed from the extracellular
space. The histidine residues presumed to be
involved in the bis-histidine metal-ion sites
which discriminate between the two models
are indicated [8]. Both models are built
according to the same general principles [5].
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Inhibition of 7TM receptor activation by designed metal-ion
sites
Upon binding of the natural agonist ligand, 7TM receptors
transmit a signal across the membrane to the intracellu-
larly associated G-protein leading to activation of down-
stream second messenger systems. In some cases, artificial
antagonists have been identified that will block receptor
activation by binding to the receptor in an unproductive
manner. In the NK-1 receptor constructs containing
bidentate or tridentate zinc sites between TM-II and TM-
III, between TM-III and TM-V, and between TM-V and
TM-VI, the functional activation of the receptor by the
agonist was inhibited by the coordination of Zn(II) [7,8].
Similarly, in rhodopsin it was found that Zn(II) inhibited
the functional coupling to the G-protein when coordi-
nated between residues on the intracellular ends of TM-
III and TM-VI [32]. In addition, disulfide cross-linking of
the intracellular ends of TM-III and TM-VI has been
observed to block rhodopsin activation [33]. Reports from
electron paramagnetic resonance studies on rhodopsin
have indicated that activation is accompanied by a rigid
body movement of TM-VI relative to TM-III [33]
(Fig. 3). This has been further supported by studies using
fluorescent probes in the b2-adrenergic receptor, which
have indicated agonist-induced conformational changes in
TM-III and TM-VI (U Gether, personal communication). 
The established network of zinc sites would indicate that
a rather extensive reorganization of the seven-helical
bundle involving multiple helices occurs during receptor
activation. Alternatively, the inhibitory effect of the coor-
dination of a metal-ion between two helices in a receptor
cannot necessarily be taken as an intrinsic indication that a
relative movement of these helices occurs during activa-
tion. It could, for example, be envisioned that the coordi-
nation of metal-ions in artificially engineered sites merely
stabilizes an inactive conformation of the receptor and
thereby prevents it from assuming the high-affinity G-
protein and agonist binding conformation. Importantly,
studies using environmentally dependent fluorescent
probes covalently attached to the receptor indicate that
antagonists do induce conformational changes which are
opposite to those induced by agonists and that both types
of conformations are different from the groundstate of the
receptor [34]. Thus, although it is tempting to suggest that
the functional inhibition caused by the motional con-
straint forced upon the receptor by the coordination of a
metal-ion in an engineered site is indicative of a specific
key conformational change occurring during receptor acti-
vation [32], such a movement in fact needs to be directly
demonstrated by electron paramagnetic resonance [33],
fluorescence measurements [34], or some other biophysi-
cal approach. Whether or not these metal-ion sites can be
used as functional probes for specific conformational
changes, it is noteworthy that all of the described metal-
ion sites involve helices that have been suggested to
perform movement upon receptor activation. However, it
would be interesting to know where high-affinity metal-
ion sites or disulfide bridges can be built between other
helices in 7TM receptors without disrupting the signal
transduction mechanism — i.e. a negative control. 
Archebacteria have so-called bacteriorhodopsins, which
are light-driven proton pumps. Like 7TM receptors, bac-
teriorhodopsins have a seven-helical structure in the
membrane [6,35–37]. Although topologically similar to
7TM receptors, bacteriorhodopsins have no associated G-
protein and they share no sequence homology to verte-
brate rhodopsins. Comparison of the projection structures
of bacteriorhodopsin and rhodopsin indicates that the
arrangement of the seven helices is clearly different as
expected from the lack of sequence homology [3]. Never-
theless, it has been observed that movement is found pre-
dominantly in the transmembrane helix corresponding to
TM-VI (F helix) of G-protein-coupled 7TM receptors, in
the connecting loop, or in both during the progress of the
photocycle of bacteriorhodopsin [38–41]. Surprisingly, this
would indicate that bacteriorhodopsin and rhodopsin, two
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Figure 3
Schematic model of the structure and
activation-dependent changes found in
rhodopsin by electron paramagnetic
resonance. In rhodopsin, magnetic dipolar
interactions between spin labels attached to
residues in the cytoplasmic ends of TM-III and
TM-VI suggest that activation is accompanied
by a rigid body movement of TM-III and TM-VI
relative to one another [33]. Similarly, in
bacteriorhodopsin, movement is also
observed to occur in the helix corresponding
to TM-VI [38–41].
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otherwise evolutionarily nonconserved and functionally
unrelated receptors, share a common structural transition
during the photocycle resulting in two very different
results, i.e. the transport of protons and activation of
trimeric GTPases.
Interestingly, no artificial metal-ion binding sites have
yet been described in 7TM receptors which mimic the
action of the natural agonist, i.e. activate the receptor
when coordinated. This could indicate that the active
species of the receptor represents a more stringent con-
formation, whereas the inactive form can be mimicked
possibly by several different conformations. Alterna-
tively, binding of the natural ligand invokes a more
complex set of interactions that cannot be fully mimic-
ked by the more simple metal-ion. Thus, metal-ion site
engineering in 7TM receptors, together with more direct
distance measurements performed by, for example, elec-
tron paramagnetic resonance analysis of double-labeled
receptors, can possibly help to solve the puzzle in the
essential but still relatively low-resolution structures
derived from the meticulous electron cryo-microscopic
analysis of 2D crystals.
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